http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2011145325-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2531-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2231-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2531-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2531-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2531-0258
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J23-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-189
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-1885
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-14
filingDate 2010-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2013-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2011145325-A
titleOfInvention CATALYTIC COMPOSITION AND METHOD OF OLIGOMERIZATION OF ETHYLENE
abstract 1. A catalytic composition comprising (a) a chromium compound; (b) a ligand of the general structure RRP-N (R) -P (R) -N (R) -H, where R, R, R, R and R are independently selected from halogen, amino, trimethylsilyl, (C-C) alkyl, substituted (C-C) alkyl, aryl and substituted aryl, or any cyclic ligand derivative, wherein at least one of the P or N atoms of the PNPNH unit can also be a member of the cyclic a system that is formed from one or more constituent ligand compounds by substitution; (c) a modifier containing an organic or inorganic halide; and (d) activator or cocatalyst. 2. The catalyst composition of claim 1, wherein the chromium compound is selected from organic or inorganic salts, coordination complexes, and organometallic complexes Cr (II) or Cr (III), preferably CrCl (THF), Cr (III) acetylacetonate, Cr (III) octanoate , chromium hexacarbonyl, Cr (III) 2-ethylhexanoate, chromium benzene (tricarbonyl) or Cr (III) chloride. 3. The catalytic composition according to claim 1 or 2, in which the modifier is selected from ammonium or phosphonium salts of the type [HE] X, [HEP] X, [HER] X, [HER] X or [ER] X, where E = N or P X = Cl, Br or I, and R = alkyl, cycloalkyl, acyl, aryl, alkenyl, alkynyl, or the corresponding combined two, three or more units; HX or RX; preferably tetraphenylphosphonium chloride, tetraethylammonium chloride monohydrate, tetraethylammonium chloride, isopropylammonium hydrochloride, triethylamine hydrochloride, tetrapropylammonium chloride, tetra-n-butylammonium chloride, tetraethylammonium tetra-ethyl-d-butyldindechloride hydrochloride, benzoyl chloride and acetyl chloride. 4. A catalytic composition comprising (a ') a chromium compound,
priorityDate 2009-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453540102
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425755001
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129771547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456726317
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11237
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID119389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448068528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449783352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20311741
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16682925
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454276626
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16682930
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7277
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451149986
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10954891
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546884
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16211205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID518677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457160489
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523843
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4072356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411832429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457000845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453787846
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID471672982
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414867724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412457046
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164911
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6367
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448677289
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453134880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16682931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546621

Total number of triples: 69.